Royal College of Psychiatrists. Consensus Statement on High-Dose Antipsychotic Medication (CR190).
Royal College of Psychiatrists, 2014.
National Institute for Health and Clinical Excellence. Psychosis and Schizophrenia in Adults: Treatment and Management (CG178).
David, AS, Adams, C, Depot antipsychotic medication in the treatment of patients with schizophrenia: (1) Meta-review; (2) Patient and nurse attitudes. Health Technol Assess,
2001; 5: 34.
Taylor, PJ, Leese, M, Williams, D, Butwell, M, Daly, R, Larkin, E. Mental disorder and violence. A special (high security) hospital study. Br J Psychiatry
1998; 172: 218–26.
Lelliot, P, Audini, B, Duffett, R. Survey of patients from an inner-London health authority in medium secure psychiatric care. Br J Psychiatry
2001; 178: 62–6.
Paton, C, Lelliott, P, Harrington, M, Okacha, C, Sensky, T, Duffett, R. Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients. J Psychopharmacol
2003; 17: 223–9.
Office for National Statistics. Ethnicity and National Identity in England and Wales: 2011.
Pereira, S, Dawson, P, Sarsam, M. The National Survey of PICU and Low Secure Services: 1. Patient characteristics. J Psychiatr Intens Care
2006; 2: 7–12.
Taylor, D, Paton, C, Kapur, S. Maudsley Prescribing Guidelines (11th edition).
Lloyd, K, Moodley, P. Psychotropic medication and ethnicity: an inpatient survey. Soc Psychiatry Psychiatr Epidemiol
1992; 27: 95–101.
Connolly, A, Taylor, D. Ethnicity and quality of antipsychotic prescribing among inpatients in South London. Br J Psychiatry
2008; 193: 161–2.
Kane, JM, Kishimoto, T, Correll, CU. Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry. J Clin Epidemiol
2013; 66: S37–41.
Hong, J, Novick, D, Brugnoli, R, Bertsch, J, Haro, JM. Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophrenia. Hum Psychopharm Clin
2013; 28: 438–46.
Zhu, B, Ascher-Svanum, H, Shi, L, Faries, D, Montgomery, W, Marder, SR. Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia. Psychiatr Serv
2008; 59: 315–17.
Stone, DC, Niz, DO. Treatment considerations in the forensic patient with schizophrenia. Curr Pharm Design
2004; 10: 2263–7.
Arango, C, Bombin, I, Gonzalez-Salvador, T, Garcia-Cabeza, I, Bobes, J. Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence. Eur Psychiat
2006; 21: 34–40.
Kirson, NY, Weiden, PJ, Yermakov, S, Huang, W, Samuelson, T, Offord, SJ, et al. Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs. J Clin Psychiat
2013; 74: 568–75.
Lafeuille, M, Laliberté-Auger, F, Lefebvre, P, Frois, C, Fastenau, J, Duh, MS. Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis. BMC Psychiatry
2013; 13: 221.
Johnson, DAW. Observations on the use of long-acting depot neuroleptic injections in the maintenance treatment of schizophrenia. J Clin Psychiat
1984; 45: 13–21.
Leucht, C, Heres, S, Kane, JM, Kissling, W, Davis, JM, Leucht, S. Oral versus depot antipsychotic drugs for schizophrenia: a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res
2011; 127: 83–92.
Haddad, PM, Chaudhry, IB, Husain, N, McLaughlin, S, Cunningham, P, David, AS, et al. Psychiatrists' attitudes to antipsychotic depot injections (i): Preferences and choice. Eur Psychiatry
2008; 23: 160–1.
Potkin, S, Bera, R, Zubek, D, Lau, G. Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia. BMC Psychiatry
2013; 13: 261.
Caroli, F, Raymondet, P, Izard, I, Plas, J, Gall, B, Delgado, A, et al. Opinions of French patients with schizophrenia regarding injectable medication. Patient Prefer Adher
2011; 5: 165–71.
Centre for Mental Health, National Mental Health Development Unit. Pathways to Unlocking Secure Mental Health Care.
Centre for Mental Health, 2011.